<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01739998</url>
  </required_header>
  <id_info>
    <org_study_id>NOBO</org_study_id>
    <nct_id>NCT01739998</nct_id>
  </id_info>
  <brief_title>Health Benefits of Functional Oil (Mega 3 Fatty Acids From Fish Oil) on Obese People</brief_title>
  <acronym>NOBO</acronym>
  <official_title>Randomized, Double-blind, Controlled Study to Evaluate the Efficacy of Omega 3 Fatty Acids on Different Inflammatory Markers in Obese Subjects With Dietary Intervention for Weight Lost</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Instituto de Investigación Hospital Universitario La Paz</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Instituto de Investigación Hospital Universitario La Paz</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Examine the effects and safety of functional oil (olive oil with omega 3 fatty acids from
      fish oil) on different inflammatory markers in obese subjects with dietary intervention for
      weight lost.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>January 2011</start_date>
  <completion_date type="Actual">March 2011</completion_date>
  <primary_completion_date type="Actual">March 2011</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Health Services Research</primary_purpose>
    <masking>Double (Participant, Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Inflammatory markers</measure>
    <time_frame>2 months</time_frame>
    <description>Inflammatory markers (Adiponectin, fibrinogen, TNFα, PAI-1 and PCR</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Anthropometric parameters</measure>
    <time_frame>0.1 and 2 months</time_frame>
    <description>Parameters measured were: Weight, Height and waist circumference, muscle mass percentage (MM%), fat mass percentage (FM%).</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Lipid profile</measure>
    <time_frame>0.1 and 2 months</time_frame>
    <description>Parameters measured were: Cholesterol, LDL-Cholesterol, HDL-Cholesterol, Triglycerides, ApoB, ApoA1 and plasma free fatty acids.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Hormonal Parameters</measure>
    <time_frame>0.2 months</time_frame>
    <description>Parameters measured were: Leptin and ghrelin</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Oxidative Stress Parameters</measure>
    <time_frame>0 and 2 months</time_frame>
    <description>Parameters measured were: plasma antioxidant capacity (FRAP, ferric reducing antioxidant power) and lipidic peroxidation (TBARS, thiobarbituric acid reactive substances assay).</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Glucosa Metabolism</measure>
    <time_frame>0, 1 and 2 months</time_frame>
    <description>Parameters measured were: glucose, basal insulin, HbA1c (in diabetic patients), HOMA index (glucemic insulin sensitivity index was calculated using the formula: HOMA-IR = fasting glucose (mmol/l)/fasting immunoreactive insulin (mU/ml)/22•5).</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Depression Test</measure>
    <time_frame>0 and 2 months</time_frame>
    <description>Parameters measured were: Beck Depression Inventory (BDI).</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Motivation and Satiety Parameters</measure>
    <time_frame>0 and 2 month</time_frame>
    <description>Parameters measured were: Visual analogue scale to assess motivation and satiety to eat.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Adeherence and Tolerance parameters</measure>
    <time_frame>up to 2 months</time_frame>
    <description>Questionnaire of adherence and tolerance to the product.</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">52</enrollment>
  <condition>Obesity</condition>
  <arm_group>
    <arm_group_label>functional oil</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Treatment consisted of consuming 5 ml of functional oil [olive oil (4 ml) with omega 3 fatty acids from fish oil (1 ml: 90% omega 3: 75-80% DHA and 10-15% EPA) Orange flavour] during the day by 8 weeks.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Placebo</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Treatment consisted of consuming 5 ml of olive oil during the day by 8 weeks</description>
  </arm_group>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>functional oil</intervention_name>
    <arm_group_label>functional oil</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Placebo</intervention_name>
    <arm_group_label>Placebo</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Men and women from 30 to 75 years old.

          -  Body mass index (BMI) ≥ 30 kg/m2

          -  Signed informed consent.

        Exclusion Criteria:

          -  Individuals with special diet due to disease as celiac disease, chronic renal failure,
             etc.

          -  Individuals with Diabetes Mellitus insulin dependent.

          -  Individuals with disorders associated with eating behaviour.

          -  Individuals with mental disease or low cognitive function.

          -  Individuals with consumption of drugs to weight lost.

          -  Individuals treated with drugs whose direct effect is on lipid profile (statins,
             fibrates, diuretics, corticosteroids or oral anti-inflammatory).

          -  Individuals with diseases that could be involucrate in weight lost (not controlled
             hypothyroidism, serious psychiatric illness, etc.)

          -  Pregnant women or lactating.

          -  Individuals with recurrent infections.

          -  Individuals with regular consumption of anti-inflammatory or glucocorticoids.

          -  Individuals with consumption of oil fish supplements (except if they gave up its
             consumption 1 month before).

          -  Individuals with fish allergy.

          -  Individuals with consumption of more than two fatty fish servers twice a week.

          -  Individuals with physical problems complying with the recommendations of physical
             activity and diet indicated.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>30 Years</minimum_age>
    <maximum_age>75 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <verification_date>November 2012</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>November 27, 2012</study_first_submitted>
  <study_first_submitted_qc>November 29, 2012</study_first_submitted_qc>
  <study_first_posted type="Estimate">December 4, 2012</study_first_posted>
  <last_update_submitted>November 29, 2012</last_update_submitted>
  <last_update_submitted_qc>November 29, 2012</last_update_submitted_qc>
  <last_update_posted type="Estimate">December 4, 2012</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

